ARCHIVES

DCPC board Oks New Grant Program For Investigators

This article is from The Cancer Letter archive.

Vol. 20 No. 09 | March 4, 1994

Download PDF Visit The Full Archive

Related Articles

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007

Jako Bows Out with Blast At NCI, Calls For IOM Review Of Cancer Program

April 15, 1988

Surgical Oncologists Certification Asked By SSO Workshop

December 9, 1983

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

November 7, 2008

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

October 1, 1993

Schwetz Replaces Koski As HHS Human Research Protections Director

February 7, 2003